Mayo Clinic Alix School of Medicine, Scottsdale, Arizona, USA.
Mayo Clinic Alix School of Medicine, Scottsdale, Arizona, USA.
World Neurosurg. 2022 Nov;167:e432-e443. doi: 10.1016/j.wneu.2022.08.038. Epub 2022 Aug 13.
Stereotactic radiosurgery is an effective treatment option for trigeminal neuralgia (TN), with frameless stereotactic radiosurgery (fSRS) allowing for a less invasive experience. A single-institutional series and systematic review of the literature were performed for cases of TN treated with fSRS.
Patients at our institution with TN that were treated with fSRS from the years 2012-2021 were included. Similarly, multiple databases were searched for studies regarding TN treated with fSRS where patient-level data was included from 2004-2020. Pain levels, via the Barrow Neurological Institute (BNI) scale, before and after treatment were analyzed. Pooled analysis was performed to compare treatment outcomes between studies using CyberKnife and LINAC modalities.
Twenty-three patients at our institution were treated with LINAC fSRS (median treatment dose: 85 Gy). Most patients had TN refractory to previous procedural treatments. Eight (35%) patients had an excellent posttreatment response (BNI I-II), while 11 (48%) patients had a good result (BNI IIIa/b). Eight patients had recurrence of pain. A total of 30 articles were included in the systematic review, encompassing 1705 patients. At last follow-up, 63.1% (774/1227) of patients endorsed an excellent response, while 16.1% (197/1227) had a good response, and 22.5% (215/957) of patients had recurrence. Pain response, facial numbness rates, and pain recurrence rates were not significantly different between CyberKnife and LINAC modalities.
Frameless SRS for TN appears to be an efficacious noninvasive option for patients with substantial comorbidities, who have failed other treatment methods, although it can be limited by higher recurrence rates.
立体定向放射外科是治疗三叉神经痛(TN)的有效选择,无框架立体定向放射外科(fSRS)可提供更微创的体验。对采用 fSRS 治疗 TN 的单机构系列和文献系统评价进行了研究。
纳入 2012 年至 2021 年期间在我院接受 fSRS 治疗的 TN 患者。同样,检索了多个数据库,查找了 2004 年至 2020 年期间包含 TN 患者采用 fSRS 治疗的患者水平数据的研究。分析治疗前后的疼痛程度(采用巴罗神经研究所(BNI)量表)。采用 CyberKnife 和 LINAC 模式对研究间的治疗结果进行了荟萃分析。
我院有 23 例患者接受 LINAC fSRS 治疗(中位治疗剂量:85 Gy)。大多数患者之前的治疗方法对 TN 无效。8 例(35%)患者治疗后反应良好(BNI I-II),11 例(48%)患者治疗结果良好(BNI IIIa/b)。8 例患者出现疼痛复发。系统评价共纳入 30 篇文章,涵盖 1705 例患者。末次随访时,1227 例患者中 63.1%(774/1227)表示有极好的反应,16.1%(197/1227)反应良好,22.5%(215/957)患者疼痛复发。CyberKnife 和 LINAC 模式之间疼痛反应、面部麻木率和疼痛复发率无显著差异。
对于有大量合并症且其他治疗方法失败的患者,无框架 SRS 治疗 TN 似乎是一种有效的非侵入性选择,尽管复发率较高可能会受到限制。